FDA applicant
Iquum, Inc.
FDA records 3 decisions for Iquum, Inc. (Marlborough, MA) from 2011 to 2016: 3 510(k) clearances. Most are in product codes OCC (Respiratory Virus Panel Nucleic Acid Assay…) and PGX (Groups A, C And G Beta-Hemolytic Streptococcus…). Its devices cite 8 predicates, 1 of them its own earlier devices. 4 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Iquum, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2016
2026 so far, outlined.
Recalls per year
1in 2021
Class I Class II/III not classified
Planning a device like Iquum, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report